Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XNW5004 in advanced prostate cancer
CTR20262220Phase 2Active
- Sponsor
- Sinovent
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of igermetostat in prostate cancer (PCa), sponsored by Sinovent. Started Jun 2026; status: active.
02
Drugs
igermetostat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20262220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262220.